Kimberly Rieger-Christ

Lahey Hospital and Medical Center

SCHOLARLY PAPERS

3

DOWNLOADS

166

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Establishment of CORONET: COVID-19 Risk in Oncology Evaluation Tool to Identify Cancer Patients at Low Versus High Risk of Severe Complications of COVID-19 Infection Upon Presentation to Hospital

Number of pages: 51 Posted: 28 Jul 2021
The Christie NHS Foundation Trust, The University of Manchester, University of Manchester - Digital Experimental Cancer Medicine, affiliation not provided to SSRN, The University of Manchester, The University of Manchester, The University of Manchester, affiliation not provided to SSRN, ITG, Inc. - ITG London, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, University of Dundee, affiliation not provided to SSRN, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, Hospital General Universitario Gregorio Marañón, affiliation not provided to SSRN, University of Southampton - University Hospital Southampton NHS Foundation Trust, Fundeni Clinical Institute, Lahey Hospital and Medical Center - Division of Cardiovascular Medicine, affiliation not provided to SSRN, University Hospitals Plymouth NHS Trust, University of Manchester - Digital Experimental Cancer Medicine, University of Manchester - Digital Experimental Cancer Medicine, Lahey Hospital and Medical Center - Division of Cardiovascular Medicine, affiliation not provided to SSRN, The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, NHS Foundation Trust - Royal Marsden Hospital, Ninewells Hospital and Medical School, affiliation not provided to SSRN, University of Manchester - Research IT, affiliation not provided to SSRN, affiliation not provided to SSRN, University College London Hospital, Government of the United Kingdom - Oncology Department, Clatterbridge Cancer Centre, University College London - UCL Cancer Institute, Sheffield Teaching Hospitals NHS Foundation Trust, University of Southampton - Cancer Sciences Academic Unit, University of Lausanne - Lausanne University Hospital, Lahey Hospital and Medical Center, affiliation not provided to SSRN, Lahey Hospital and Medical Center - Department of Internal Medicine, affiliation not provided to SSRN, Centre Hospitalier Universitaire Vaudois (CHUV), Lahey Hospital and Medical Center, Bristol Haematology and Oncology Centre, affiliation not provided to SSRN, PSL Research University - Institut Curie, Royal Cornwall Hospital - Sunrise Centre, I.M. Sechenov First Moscow State Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, National Institute for Health Research (NIHR), Government of the United Kingdom - Oncology Department, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Hospital Universitario La Paz - Department of Medical Oncology, The Christie NHS Foundation Trust, Government of the United Kingdom - Weston Park Cancer Centre, Government of the United Kingdom - Weston Park Cancer Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, The Christie NHS Foundation Trust, Independent, The University of Manchester, The University of Manchester and The Christie NHS Foundation Trust
Downloads 106 (524,864)

Abstract:

Loading...

COVID-19, cancer, SARS-CoV-2, decision support tool; CORONET

2.

A Nasal Genomic Test To Evaluate Lung Cancer Risk in Patients with Pulmonary Nodules

Number of pages: 27 Posted: 21 Apr 2022
Lahey Hospital and Medical Center, Lahey Hospital and Medical Center, University of Utah - Health Sciences Center, Veracyte, Inc., Veracyte, Inc., Veracyte, Inc., Veracyte, Inc., Veracyte, Inc., Duke University - School of Medicine, Geisel School of Medicine at Dartmouth, Johnson & Johnson, Veracyte, Inc. and Cleveland Clinic
Downloads 43 (841,501)

Abstract:

Loading...

Nasal Genomic Classifier, Pulmonary Nodule, Lung Nodule, lung cancer, Early Detection

3.

Vascular Invasion Identifies the Most Aggressive Histologic Subset of Stage I Lung Adenocarcinoma: Implications for Adjuvant Therapy

Number of pages: 22 Posted: 29 Apr 2022
affiliation not provided to SSRN, Lahey Hospital and Medical Center, Lahey Hospital and Medical Center, Lahey Hospital and Medical Center, Lahey Hospital and Medical Center, Lahey Hospital and Medical Center, Harvard University - Dana-Farber Cancer Institute, Inova Health System and Boston University - Department of Pathology and Laboratory Medicine
Downloads 17 (1,103,989)

Abstract:

Loading...

adenocarcinoma, WHO grade, vascular invasion, angioinvasion, LMP